Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Open-Label Study to Evaluate Efficacy of Combination Treatment With MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients With Recurrent/Metastatic Human Papilloma Virus Associated Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03439085
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:23.770358+00:00
Published At
2024-07-09T00:00:00+00:00
Record Updated At
2024-07-09
Results Posted At
2024-07-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Human Papillomavirus-16 Positive", "Human Papillomavirus-18 Positive", "Metastatic Malignant Neoplasm", "Recurrent Anal Canal Carcinoma", "Recurrent Cervical Carcinoma", "Recurrent Malignant Neoplasm", "Recurrent Penile Carcinoma", "Recurrent Vaginal Carcinoma", "Recurrent Vulvar Carcinoma", "Refractory Malignant Neoplasm", "Stage IV Anal Cancer AJCC v8", "Stage IV Cervical Cancer AJCC v8", "Stage IV Penile Cancer AJCC v8", "Stage IV Vaginal Cancer AJCC v8", "Stage IV Vulvar Cancer AJCC v8", "Stage IVA Cervical Cancer AJCC v8", "Stage IVA Vaginal Cancer AJCC v8", "Stage IVA Vulvar Cancer AJCC v8", "Stage IVB Cervical Cancer AJCC v8", "Stage IVB Vaginal Cancer AJCC v8", "Stage IVB Vulvar Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-07-09"
protocolSection.identificationModule.nctId
"NCT03439085"
protocolSection.identificationModule.officialTitle
"A Phase 2, Open-Label Study to Evaluate Efficacy of Combination Treatment With MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients With Recurrent/Metastatic Human Papilloma Virus Associated Cancers"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-07-09"

Study condition terms

  • Human Papillomavirus-16 Positive (protocolSection.conditionsModule.conditions)
  • Human Papillomavirus-18 Positive (protocolSection.conditionsModule.conditions)
  • Metastatic Malignant Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Anal Canal Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Cervical Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Malignant Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Penile Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Vaginal Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Vulvar Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Malignant Neoplasm (protocolSection.conditionsModule.conditions)
  • Stage IV Anal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Cervical Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Penile Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Vaginal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Vulvar Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Cervical Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Vaginal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Vulvar Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Cervical Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Vaginal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Vulvar Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.